Home- Research
- Conferences
- Workshops & Training
- Program
- Overview
- *Innovation Cafe
- Drug Safety
- Counterfeit Drugs
- Valuation & Auditing
- Drug Discovery Innovation
- Drug Development
- Complex Systems & Org. Development
- Semantic Web
- R&D Knowledge Management
- Abstracts
- Speakers
- Allemand, P
- Barrett, J
- Gardner, S
- Gates, P
- Gibbs, A
- Hardy, B
- Henrick, K
- Jautelat, R
- Jordis, U
- Kanagy, J
- Liebman, M
- Montano, B
- Newman, V
- Polsky-Newman, R
- Scoffin, R
- Sharp, M
- Spitzner, J
- Starry, S
- Weintraub, H
- Wikel, J
- Molecular Medicine
- Nanobiotech
- Personalised Medicine
- Exhibition
- Registration
- About
- Overview
- Contact
- Support
- Schedule
|
|
|
|
|
|
|
|
|
| Pierre Allemand, Ph.D., Director, Business Development, Symyx AG |
|
| Born in 1959, Dr Pierre Allemand has studied chemistry at the University of Neuchatel (Switzerland) where he has obtained his Ph.D. in 1988. Computer passionate, he co-founded FAB research in parallel with his thesis activities and developed software for scientific and non-scientific applications. In 1988 he joined MDL and held different positions, both in Europe and in the US, in sales and as head of consulting. In 1999 he joined Spotfire and opened the Swiss and French markets. He then joined Brightrivers, a startup at the EPFL specialized in a holistic approach to production optimization, and finally joined Symyx in the summer of 2004 as responsible for sales in the pharmaceutical sector in Switzerland and Germany.
|
|
|
|
Global information integration in R&D
Pierre Allemand, Ph.D., Director, Business Development, Symyx AG
The pharmaceutical industry is facing a formidable challenge. On one hand, it is important to gather more and more information at each step of the R&D process, on the other hand, this information is important to more and more people along the complex drug discovery and design chain. This exponential increase in information sharing, compounded by the introduction of parallel methods at all stages of the process, requires a change in mentality about how to deal with knowledge in a pharmaceutical R&D organisation.
This presentation will discuss how such global information flows can be handled and what impact handling those has, both on the way of working and the way of thinking that corporations have to introduce to survive. It will also cover examples of how a global information management network can help companies reach the next level necessary in this context. Some pitfalls and dangers of information strategies will be explored to illustrate this vision.
|
|
|
|
|
|
|
